Mizuho raises Cardinal Health price target to $280
The target increase supports a bullish view, though it is an analyst opinion rather than a guarantee of performance.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The target increase supports a bullish view, though it is an analyst opinion rather than a guarantee of performance.
What happened, with direct paths to the underlying reporting
Mizuho raised its CAH price target from $250 to $280. The new target is about 11% above the posted price of $252.65.
Target: $280
Posted price: $252.65
Analyst firm: Mizuho Securities
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.